Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Op-Ed: Life Sciences Are Key to Building an ‘Innovation Economy’ in New Jersey

By Dean J. Paranicas, President & CEO, HealthCare Institute of New Jersey (HINJ)  A core component of Gov. Murphy’s policy agenda is an “innovation economy.” We agree, as other states, countries and regions, looking to redefine their own economies, have become increasingly aggressive in attracting investment from innovator industries. If the bidding for Amazon’s second headquarters is any indication, the competition will only intensify. Read more here.

NJBIZ publishes Health Care Power 50

The NJBIZ Health Care Power 50 list includes the CEOs of Celgene, HINJ, Johnson & Johnson, Merck and SCYNEXIS. The full list is here: https://njbiz.com/2019-njbiz-health-care-power-50/

Navigating Healthcare Forum 2019 in Glassboro July 17

The Southern New Jersey Development Council will be holding its annual Navigating Healthcare Forum July 17 from 8 a.m. to 1:30 p.m. in Rowan University’s Chamberlain Student Center, 201 Mullica Hill Road, Glassboro. Panelists include Inspira Health President John DiAngleo, AtlanticCare President and CEO Lori Herndon and Shabbir Imber Shafdar, executive director, Partnership for Safe Medicines. Read more, register here.

Partners Launch New Statewide Campaign Aimed at Preventing Drug Diversion

From 6ABC Philadelphia: A new campaign about prescription drug abuse takes aim at people in New Jersey who are selling homes. The HealthCare Institute of New Jersey, N.J. Realtors, PhRMA and Partnership for a Drug-Free New Jersey announced the ‘Safe Home, Safe Sale’ campaign Feb. 19. You can read more in the NJBIZ story and on the campaign website.]

HINJ Board Chair Alex Kelly of Allergan was among the speakers at the Feb. 19 event.

 

Rutgers Hosts Safe Patient Handling Event

The New Jersey Department of Health and Department of Labor are co-sponsoring a Safe Patient Handling Conference on March 19 at the Rutgers Busch Campus Center in collaboration with the New Jersey Hospital Association and the New Jersey Work Environment Council Health Professionals and Allied Employees.  More information is posted here.

Annual Conference Draws Healthy Crowd

The NJLSVA annual vendors conference was held on Nov. 13 at Porzio Life Sciences in Morristown. Speakers included procurement officials from Eli Lilly and Sanofi; Assemblyman Andrew Zwicker, (D-Somerset), who chairs the Assembly Science, Innovation and Technology Committee; Assemblyman Chris DePhillips (R-Bergen) a committee member; and representatives from the New Jersey Business Action Center and U.S. Small Business Administration. Despite the rainy weather and traffic tie-ups, more than 80 vendors attended. The event was moderated by Dean Paranicas, president and chief executive officer of the HealthCare Institute of New Jersey (HINJ) and organized by Haskell Berman, HINJ senior vice president, state affairs.

four guys

From Left: Haskell Berman of HINJ, Assemblymen Andrew Zwicker and Chris DePhillips and Dean Paranicas of HINJ.

2018 Regional Academic Drug Discovery Conference

The N.J. Academic Drug Discovery Consortium second annual meeting will be held Nov. 15 at Rutgers University in Piscataway. Read more and register here.

 

New Jersey’s Connected Economy: Measuring the Ripple Effect of Economic Policy

This in-depth new report from NJPRO, the New Jersey Policy Research Organization, is relevant to every industry in New Jersey, elected officials, and citizens.

Zwicker on biotech report: Public dollars, leveraged with private dollars, are key to innovation

Andrew Zwicker, who earned his Ph.D. in physics from Johns Hopkins and serves as the head of the Science Education Department of the Princeton Plasma Physics Laboratory, knows a little bit about funding. That is why the Democratic Assemblyman from the 16th District said he is optimistic about the direction the state is going. Zwicker served as vice chair of the state’s Biotechnology Task Force, which released a 44-page report June 13 on how to reinvigorate the state’s life science industry the right way.

Read more here.

The ‘State’ of New Jersey’s Innovative Industries

From New Jersey Business Magazine